![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Advances in treatment of mental illness is topic of symposium
A symposium on recent discoveries in basic and clinical neuroscience and their promise for revolutionary advances in the diagnosis, treatment and prevention of mental illness will be held at the School of Medicine on Saturday, March 27.
The event, titled "Towards Recovery from Mental Illness: Integrating Psychiatric Treatments," is aimed at mental health professionals as well as people affected by mental illness and their families. The symposium will be held in Harkness Auditorium, 333 Cedar St. It will begin at 8 a.m. and adjourn at 1 p.m. There is no charge.
Opening remarks will be delivered by Arthur Evans, deputy commissioner of the Connecticut Department of Mental Health; Dr. Benjamin Bunney, the Charles B.G. Murphy Professor and chair of psychiatry; Dr. John Krystal, the Robert L. McNeil Jr. Professor of Clinical Pharmacology and deputy chair for research in psychiatry; and Marilyn Ricci, president of the Connecticut branch of the National Alliance for the Mentally Ill.
Topics will include the developmental hypothesis of schizophrenia; new medications for the treatment of schizophrenia: mechanisms, opportunities and side effects; integrating psychotherapy and services for schizophrenia; integrating psychotherapy and pharmacotherapy for substance use disorders; and understanding the social disability of autism.
The speakers, all from Yale, will be Dr. Pasko Rakic, Dr. D. Cyril D'Souza, Dr. Robert Rosenheck, Dr. Bruce Rounsaville, Dr. Fred Volkmar and Professor Joan Kaufman, who will lead a general discussion with the speakers.
In addition to Yale's Connecticut Mental Health Center and Department of Psychiatry, the symposium is sponsored by the Connecticut Department of Mental Health and Addiction Services; the Connecticut chapter of the National Alliance for the Mentally Ill, and the Yale Mental Health Education Program. Support was provided by the American College of Neuropsychopharmacology.
T H I S
|